Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FRMM9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,567
Award facts
- Contract value 100% obligated
- $28,567.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $28,567.49 for Wegovy 1.7 mg/0.75 mL pen injectors with a completion date of June 10, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor. The company's federal contract portfolio demonstrates extensive experience delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Wegovy, an injectable diabetes medication, exemplifies the company's role in supplying specialty pharmaceutical products to support federal military and veteran healthcare needs through the DLA's pharmaceutical prime vendor network.
Quick answers
Who was awarded contract SPE2DB25FRMM9?
SPE2DB25FRMM9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 9, 2025.
How much is contract SPE2DB25FRMM9 worth?
The government has obligated $28,567 on SPE2DB25FRMM9.
Is contract SPE2DB25FRMM9 an order under another contract?
Yes. SPE2DB25FRMM9 is a delivery order under SPE2DB20D3101, an indefinite delivery contract.
Was contract SPE2DB25FRMM9 competed?
The extent of competition for SPE2DB25FRMM9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award